Stay updated on Fluticasone/Formoterol K-haler vs ICS/LABA in Asthma Clinical Trial

Sign up to get notified when there's something new on the Fluticasone/Formoterol K-haler vs ICS/LABA in Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fluticasone/Formoterol K-haler vs ICS/LABA in Asthma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the clinical trial to compare efficiency in controlling symptoms between Fluticasone Propionate/Formoterol K-haler (Medium Strength) and High Strength ICS/LABA in patients with persistent asthma.
    Difference
    0.1%
    Check dated 2024-06-06T14:38:09.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing a more detailed explanation of eligibility criteria and examples such as general health condition or prior treatments. This change likely pertains to medical and healthcare-related documentation.
    Difference
    23%
    Check dated 2024-05-22T21:20:23.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:24:57.000Z thumbnail image

Stay in the know with updates to Fluticasone/Formoterol K-haler vs ICS/LABA in Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fluticasone/Formoterol K-haler vs ICS/LABA in Asthma Clinical Trial page.